Abbott Laboratories (SNSE:ABT)

Market Cap	207.99T
Revenue (ttm)	42.16T
Net Income (ttm)	13.39T
Shares Out	n/a
EPS (ttm)	7,655.16
PE Ratio	15.53
Forward PE	23.06
Dividend	2,298.30 (1,717.59%)
Ex-Dividend Date	Oct 15, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	133.81
Day's Range	n/a
52-Week Range	110.16 - 135.90
Beta	n/a
RSI	100.00
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Santiago Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD